Headline News about Denali Therapeutics Inc![]()
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Via Benzinga
![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Via Benzinga
![]()
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 18, 2022
Via Benzinga
![]() ![]()
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
Via Benzinga
Exposures
Product Safety
![]() Via Benzinga
![]() ![]() ![]()
President And CEO Of Denali Therapeutics Sold $1.00 Million In Stock
September 03, 2021
Via Benzinga
Topics
Regulatory Compliance
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|